All companies
Visit website
NOPALERA
OperatingNOPALERA INC
Healthcare · Founded 2019
Latina owned, clean skincare with $3.2M of revenue
Valuation cap ⓘ
$15.0M
As of May 2024 · from NOPALERA Future Equity SAFE 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$283,980
Across 1 round since 2024
Latest share price
$1.00
NOPALERA Future Equity SAFE 1 offering price
Financials
FY2021–FY2024 · from SEC filings · hover any figure for its source$624K
2021
$1.8M
−$388K
2022
$1.8M
−$1.5M
2023
$2.2M
−$1.3M
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$623,604
$1,782,537
$1,782,537
$2,150,057
Cost of goods sold
$255,068
$725,655
$725,655
$790,885
Gross margin
59%
59%
59%
63%
Net income
—
-$388,222
-$1,543,991
-$1,317,366
Taxes paid
$0
$0
$0
$6,100
Balance sheet
Cash
$1,966,714
$478,476
$478,476
$332,996
Accounts receivable
$8,142
$14,236
$14,236
$54,058
Total assets
$2,224,994
$1,209,881
$1,209,881
$1,004,791
Short-term debt
$139,686
$381,923
$381,923
$605,825
Long-term debt
$0
$30,000
$30,000
$0
Total liabilities
$139,686
$411,923
$411,923
$605,825
Other
Headcount
—
—
6
5
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$15.0M
Valuation cap
NOPALERA Future Equity SAFE 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $284K / $500KInvestors 415Valuation cap $15M
Reg CF annual-report compliance
Delinquent
Filed 1 of 2 annual reports (FY2024–FY2025)
Missing: 2025
415 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001952398Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.